A Las Vegas man, Mykalai Kontilai, receives a 51-month prison sentence and a $6.1 million restitution order for a multi-million dollar investment fraud. Separately, the SEC charges Kiromic BioPharma’s former CEO and CFO with failing to disclose material information before a public offering.